Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study (Q33880221)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study |
scientific article |
Statements
1 reference
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study (English)
1 reference
Jean-Michel Molina
1 reference
Garrett Nichols
1 reference
Franco Maggiolo
1 reference
Giovanni Penco
1 reference
David Wright
1 reference
Robert Grossberg
1 reference
Julie Chas
1 reference
Jacques Durant
1 reference
Santiago Moreno
1 reference
Manuela Doroana
1 reference
Mounir Ait-Khaled
1 reference
Jenny Huang
1 reference
Sherene Min
1 reference
Ivy Song
1 reference
Cindy Vavro
1 reference
Jane M Yeo
1 reference
VIKING-3 Study Group
1 reference
19 January 2014
1 reference
1 reference
210
1 reference
354-362
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference